Poly (ADP-ribose) polymerase inhibition: past, present and future
The process of poly (ADP-ribosyl) ation and the major enzyme that catalyses this reaction,
poly (ADP-ribose) polymerase 1 (PARP1), were discovered more than 50 years ago. Since …
poly (ADP-ribose) polymerase 1 (PARP1), were discovered more than 50 years ago. Since …
ADP-ribosylation from molecular mechanisms to therapeutic implications
ADP-ribosylation is a ubiquitous modification of biomolecules, including proteins and
nucleic acids, that regulates various cellular functions in all kingdoms of life. The recent …
nucleic acids, that regulates various cellular functions in all kingdoms of life. The recent …
ADP‐ribosyltransferases, an update on function and nomenclature
ADP‐ribosylation, a modification of proteins, nucleic acids, and metabolites, confers broad
functions, including roles in stress responses elicited, for example, by DNA damage and …
functions, including roles in stress responses elicited, for example, by DNA damage and …
Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling
EJ Longarini, H Dauben, C Locatelli, AR Wondisford… - Molecular Cell, 2023 - cell.com
PARP1, an established anti-cancer target that regulates many cellular pathways, including
DNA repair signaling, has been intensely studied for decades as a poly (ADP-ribosyl) …
DNA repair signaling, has been intensely studied for decades as a poly (ADP-ribosyl) …
Click chemistry in proteomic investigations
Despite advances in genetic and proteomic techniques, a complete portrait of the proteome
and its complement of dynamic interactions and modifications remains a lofty, and as of yet …
and its complement of dynamic interactions and modifications remains a lofty, and as of yet …
Rational design and synthesis of novel dual PROTACs for simultaneous degradation of EGFR and PARP
Inspired by the success of dual-targeting drugs, especially bispecific antibodies, we propose
to combine the concept of proteolysis targeting chimera (PROTAC) and dual targeting to …
to combine the concept of proteolysis targeting chimera (PROTAC) and dual targeting to …
[HTML][HTML] PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
JM Gozgit, MM Vasbinder, RP Abo, K Kunii… - Cancer Cell, 2021 - cell.com
PARP7 is a monoPARP that catalyzes the transfer of single units of ADP-ribose onto
substrates to change their function. Here, we identify PARP7 as a negative regulator of …
substrates to change their function. Here, we identify PARP7 as a negative regulator of …
Niacin in the central nervous system: an update of biological aspects and clinical applications
V Gasperi, M Sibilano, I Savini, MV Catani - International journal of …, 2019 - mdpi.com
Niacin (also known as “vitamin B3” or “vitamin PP”) includes two vitamers (nicotinic acid and
nicotinamide) giving rise to the coenzymatic forms nicotinamide adenine dinucleotide (NAD) …
nicotinamide) giving rise to the coenzymatic forms nicotinamide adenine dinucleotide (NAD) …
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Q Zhong, X **ao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …
Post-translational modifications in liquid-liquid phase separation: a comprehensive review
Liquid-liquid phase separation (LLPS) has received significant attention in recent biological
studies. It refers to a phenomenon that biomolecule exceeds the solubility, condensates and …
studies. It refers to a phenomenon that biomolecule exceeds the solubility, condensates and …